Editorial: Cancer diagnosis and novel drug discovery based on microbiome

Frontiers in Microbiology

Microbiology

Ge Zhang¹  Jianhui Wang²  Peng Chen³ 

[1] Department of Microbial and Biochemical Pharmacy, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China;Department of Pathology, Yale University, New Haven, CT, United States;School of Pharmacy, Lanzhou University, Lanzhou, Gansu, China;

关键词: microbiome;    high throughput sequencing;    cancer;    diagnosis;    drug discovery;   

DOI  :  10.3389/fmicb.2023.1144986

 received in 2023-01-15, accepted in 2023-03-30,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Chen, Zhang and Wang.